Title: The Role of Th1 and Th2 Cells for Mucosal IgA Responsesa
Abstract: Annals of the New York Academy of SciencesVolume 778, Issue 1 p. 64-71 The Role of Th1 and Th2 Cells for Mucosal IgA Responsesa MASAFUMI YAMAMOTO, MASAFUMI YAMAMOTO The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorJOHN L. VANCOTT, JOHN L. VANCOTT The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorNOBUO OKAHASHI, NOBUO OKAHASHI The Department of Mucosal Immunology Research Institute for Microbial Diseases Osaka University Suita, Osaka 565, JapanSearch for more papers by this authorMARIAROSARIA MARINARO, MARIAROSARIA MARINARO The Department of Mucosal Immunology Research Institute for Microbial Diseases Osaka University Suita, Osaka 565, JapanSearch for more papers by this authorHIROSHI KIYONO, HIROSHI KIYONO The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorKOHTARO FUJIHASHI, KOHTARO FUJIHASHI The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorRAYMOND J. JACKSON, RAYMOND J. JACKSON The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorSTEVEN N. CHATFIELD, STEVEN N. CHATFIELD Vaccine Research Unit Imperial College of Science London, United KingdomSearch for more papers by this authorHORST BLUETHMANN, HORST BLUETHMANN Hoffmann-La Roche AG CH-4002, Basel, SwitzerlandSearch for more papers by this authorJERRY R. McGHEE, JERRY R. McGHEE The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this author MASAFUMI YAMAMOTO, MASAFUMI YAMAMOTO The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorJOHN L. VANCOTT, JOHN L. VANCOTT The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorNOBUO OKAHASHI, NOBUO OKAHASHI The Department of Mucosal Immunology Research Institute for Microbial Diseases Osaka University Suita, Osaka 565, JapanSearch for more papers by this authorMARIAROSARIA MARINARO, MARIAROSARIA MARINARO The Department of Mucosal Immunology Research Institute for Microbial Diseases Osaka University Suita, Osaka 565, JapanSearch for more papers by this authorHIROSHI KIYONO, HIROSHI KIYONO The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorKOHTARO FUJIHASHI, KOHTARO FUJIHASHI The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorRAYMOND J. JACKSON, RAYMOND J. JACKSON The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorSTEVEN N. CHATFIELD, STEVEN N. CHATFIELD Vaccine Research Unit Imperial College of Science London, United KingdomSearch for more papers by this authorHORST BLUETHMANN, HORST BLUETHMANN Hoffmann-La Roche AG CH-4002, Basel, SwitzerlandSearch for more papers by this authorJERRY R. McGHEE, JERRY R. McGHEE The Immunobiology Vaccine Center The Departments of Microbiology and Oral Biology University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this author First published: February 1996 https://doi.org/10.1111/j.1749-6632.1996.tb21115.xCitations: 87 † 'This work was supported by NIH Contract A1 15128 and Grants A1 18958, DK 44240, DE08228. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Mestecky, J. & J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40: 153–245. 2 McGhee, J. R., J. Mestecky, C. O. Elson & H. Kiyono. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9: 175–199. 3 Hanson, L. A. & P. Brandtzaeg. 1989. The mucosal defence system. In Immunobiological Disorders in Infant and Children. E.R. Stiehm, Ed.: 116–155. W. B. Saunders Company. Philadelphia , PA . 4 Mosmann, T. R. & R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functioinal properties. Annu. Rev. Immunol. 7: 145–173. 5 Beagley, K. W., J. H. Eldridge, F. Lee, H. Kiyono, M. P. Everson, W. J. Koopman, T. Hirono, T. Kishimoto & J. R. McGhee. 1989. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169: 2133–2148. 6 Beagley, K. W., J. H. Eldridge, W. K. Aicher, J. Mestecky, S. DiFabio, H. Kiyono, H. & J. R. McGhee. 1991. Peyer's patch B cells with memory cell characteristics undergo terminal differentiation within 24 hours in response to interleukin-6. Cytokine 3: 107–116. 7 Fujihashi, K., J. R. McGhee, C. Lue, K. W. Beagley, T. Taga, T. Hirano, T. Kishimoto, J. Mestecky & H. Kiyono. 1991. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J. Clin. Invest. 88: 248–252. 8 Murray, P. D., D. T. McKenzie, S. L. Swain & M. F. Kagnoff. 1987. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunogloblin A expression. J. Immunol. 139: 2669–2674. 9 Coffman, R. L., B. Shrader, J. Carty, T. R. Mossman & M. W. Bond. 1987. A mouse T cell product that preferentially enhances IgA productioin. I. Biologic characterization. J. Immunol. 139: 3685–3690. 10 Bond, M. W., B. Shrader, T. R. Mossman & R. L. Coffman. 1987. A mouse T cell product that preferentially enhances IgA production. II. Physicochemical characterization. J. Immunol. 139: 3691–3696. 11 Harriman, G. R., D. Y. Kunimoto, J. F. Elliott, V. Paetkau & W. Strober. 1988. The role of IL-5 in IgA B cell differentiation. J. Immunol. 140: 3033–3039. 12 Lebman, D. A. & R. L. Coffman. 1988. The effects of IL-4 and IL-5 on the IgA response by murine Peyer's patch B cell subpopulations. J. Immunol. 141: 2050–2056. 13 Ramsay, A. J., A. J. Husband, I. A. Ramshaw, S. Bao, K. I. Matthaei, G. Kohler & M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264: 561–563. 14 Jackson, R. J., K. Fujihashi, J. Xu-Amano, H. Kiyono, C. O. Elson & J. R. McGhee. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61: 4272–4279. 15 Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai & J. R. McGhee. 1993. Helper T cell subsets for immunogloblin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178: 1309–1320. 16 Xu-Amano, J., R. J. Jackson, K. Fujihashi, H. Kiyono, H. F. Staats & J. R. McGhee. 1993. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12: 903–911. 17 Marinaro, M., H. F. Staats, T. Hiroi, M. Coste, R. J. Jackson, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, M. Blüthmann, K. Fujihashi & J. R. McGhee. 1995. The mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. In press. 18 Curtiss III, R., S. M. Kelly & J. O. Hassan. 1993. Live oral avirulent Salmonella vaccines. Vet. Microbiol. 37: 397–405. 19 Chatfield, S. N., M. Roberts, P. London, I. Cropley, G. Douce & G. Dougan. 1993. The development of oral vaccines based on live attenuated Salmonella strains. FEMS Immunol. Med Microbiol. 7: 1–7. 20 Roberts, M., S. N. Chatfield & G. Dougan. 1994. Salmonella as carriers of heterologous antigens. In Novel Delivery Systems for Oral Vaccines. D. T. O'Hagan, Ed.: 27–58. CRC Press. Ann Arbor , ME . 21 Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater & N. F. Fairwather. 1992. Use of the nirB promoter to direct the stable expression of heterogous antigens in Salmonella oral vaccine strains: development of a single dose oral tetanus vaccine. Biotechnology 10: 888–892. 22 Locksley, R. M. & P. Scott. 1991. Helper T-cell subsets in mouse Leishmaniasis: induction, expansion and effector functioin. Immunol. Today 12: A58–A61. 23 Scott, P. 1991. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous Leishmaniasis. J. Immunol. 147: 3149–3155. 24 Zhong, G. M. & L. M. de la Maza. 1988. Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma IFN inhibits the growth of Chlamydia trachomatis serotype L1. Infect. Immun. 56: 3322–3325. 25 Flesch, I. & S. H. E. Kaufmann. 1987. Mycobacterial growth inhibition by interferongamma activated bone marrow macrophages and differential susceptibility among strains of M. tuberculosis. J. Immunol. 138: 4408–4413. 26 Muotiala, A. & H. P. Makela. 1990. The role of IFN-γ in murine Salmonella typhimurium infection. Microb. Pathog. 8: 135–141. 27 Ramarathinam, L., D. W. Niesel & G. R. Klimpel. 1993. Salmonella typhimurium induces IFN-γ production in murine splenocytes. Role of natural killer cells and macrophages. J. Immunol. 150: 3937–3981. 28 Ramarathinam, L., R. A. Shaban, D. W. Neisel & G. R. Klimpel. 1991. Interferon gamma (IFN-γ) production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microb. Pathog. 11: 347–356. 29 Mastroeni, P., B. Villarreal-Ramos & C. E. Hormaeche. 1992. Role of T cells, TNF-α and IFN-γ in recall of immunity to oral challenge with virulent Salmonella in mice vaccinated with live attenuated aro-Salmonella vaccines. Microb. Pathog. 13: 477–491. 30 VanCott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, P.B. Carter, H. Kiyono & J. R. McGhee. 1995. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. In press. 31 Coffman, R. L., K. Varkila, P. Scott & R. Chatelain. 1991. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol. Rev. 123: 189–207. 32 Beagley, K. W., J. H. Eldridge, H. Kiyono, M. P. Everson, W. J. Koopman, T. Honjo & J. R. McGhee. 1988. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J. Immunol. 141: 2035–2042. 33 Briere, F., J.-M. Bridon, D. Chevet, G. Souillet, F. Bienvenu, C. Guret, H. Martinez-Valdez & J. Banchereau. 1994. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J. Clin. Invest. 94: 97–104. 34 LeGros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman & W. E. Paul. 1990. Generation of interleukin-4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172: 921–929. 35 Swain, S. L., A. D. Weinberg, M. English & G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145: 3796–3806. 36 Sad, S. & T. R. Mosmann. 1994. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153: 3514–3522. 37 Kopf, M., G. L. Gros, M. Bachmann, M. C. Lamers, H. Blüthmann & G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248. 38 Okahashi, N., M. Yamamoto, J. L. Vancott, S. N. Chatfield, M. Roberts, H. Blüthmann, T. Hiroi, H. Kiyono & J. R. McGhee. 1995. Oral immunization of IL-4 knockout mice with rSalmonella or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are assoicated with mucosal IgA responses. Submitted to Infect. Immun. 39 Vajdy, M., M. H. Kosco-Vilbois, M. Kopf, G. Kohler & N. Lycke. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181: 41–53. Citing Literature Volume778, Issue1Oral Tolerance: Mechanisms and ApplicationsFebruary 1996Pages 64-71 ReferencesRelatedInformation
Publication Year: 1996
Publication Date: 1996-02-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 97
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot